STOCK TITAN

Evolv Technologies Holdings (EVLV) Financials

EVLV NASDAQ
Trailing 12 months to September 30, 2026
Revenue $175.9M +28.9% YoY
Net Income -$19.0M n/m YoY
EPS (Diluted) -$0.11 n/m YoY
Operating Cash Flow $42.3M +570.5% YoY
Market Cap $709.2M as of Nov 19, 2026
Price / Sales 4.0x on $175.9M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 6.6x on $107.8M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EVLV SEC filings page.

Evolv Technologies Holdings, Inc. (EVLV) reported $175.9M in revenue over the twelve months to Sep 30, 2026, up 28.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EVLV FY2025

The business is growing quickly, but FY2025 still combined margin compression, operating losses, and a balance sheet increasingly funded by liabilities.

The key shift is that FY2025 produced positive operating cash flow of $18.7M alongside a net loss of $33.1M, indicating working-capital or non-cash effects—not accounting earnings—drove cash conversion that year. With a current ratio of 1.2x and liabilities at 60.8% of assets, that conversion occurred alongside a tighter short-term funding structure.

Revenue reached $145.9M in FY2025, but gross margin slipped to 51.6%, so growth did not fully preserve unit economics. The simultaneous 59.0% cost-of-revenue increase and 14.3% SG&A reduction shifted the problem downstream: gross economics weakened while operating losses narrowed.

Liabilities reached $185.0M against equity of $119.4M, making the capital structure liability-heavy. Debt-to-equity was only 0.2x, so that pressure is not explained by long-term borrowing alone; investing cash flow of -$41.8M also exceeded operating cash generation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 66 / 100
Financial Health Score 66/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Evolv Technologies Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
87

Evolv Technologies Holdings, Inc. held $69.0M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $18.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Evolv Technologies Holdings, Inc. scores 87/100 among other emerging companies.

Dilution
60

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. Evolv Technologies Holdings, Inc. scores 60/100 on it among other emerging companies.

R&D Intensity
39

Evolv Technologies Holdings, Inc. spent $20.6M on research and development in fiscal year 2025, which was 10.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Evolv Technologies Holdings, Inc. scores 39/100 among other emerging companies.

Revenue Progress
73

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Evolv Technologies Holdings, Inc. scores 73/100 on it among other emerging companies.

Burn Trend
98

Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Evolv Technologies Holdings, Inc. scores 98/100 on it among other emerging companies.

Balance Sheet
38

Evolv Technologies Holdings, Inc.'s cash, cash equivalents and investments came to $69.0M at the end of fiscal year 2025, against $185.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Evolv Technologies Holdings, Inc. scores 38/100 among other emerging companies.

Altman Z-Score Distress
0.58

Evolv Technologies Holdings, Inc. scores 0.58, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $387.8M against total assets of $304.4M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

Evolv Technologies Holdings, Inc. passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.

Earnings Quality Mixed
N/A

Evolv Technologies Holdings, Inc. reported a net loss of $33.1M while generating $18.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Evolv Technologies Holdings, Inc. reported an operating loss of $48.5M against $1.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$47.3M
YoY+10.5%
QoQ+8.2%
5Y CAGR+41.2%

Evolv Technologies Holdings, Inc. generated $47.3M in revenue in Q3 2026. This represents an increase of 10.5% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.

EBITDA
-$6.9M
YoYn/m
QoQn/m

Evolv Technologies Holdings, Inc.'s EBITDA was -$6.9M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$15.6M
YoYn/m
QoQn/m

Evolv Technologies Holdings, Inc. reported a net loss of $15.6M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.09
YoYn/m
QoQn/m

Evolv Technologies Holdings, Inc. earned -$0.09 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Cash & Debt
$61.9M
YoY+96.5%
QoQ+17.5%
5Y CAGR-28.6%

Evolv Technologies Holdings, Inc. held $61.9M in cash against $28.8M in long-term debt as of Q3 2026.

Shares Outstanding
181M
YoY+3.9%
QoQ+0.1%
5Y CAGR+5.0%

Evolv Technologies Holdings, Inc. had 181M shares outstanding in Q3 2026. This represents an increase of 3.9% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
49.7%
YoY0.0pp
QoQ-0.4pp
5Y change+8.6pp

Evolv Technologies Holdings, Inc.'s gross margin was 49.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Operating Margin
-30.4%
YoY-10.4pp
QoQ-6.3pp

Evolv Technologies Holdings, Inc.'s operating margin was -30.4% in Q3 2026, reflecting core business profitability. This is down 10.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.3 percentage points.

Net Margin
-32.9%
YoY-28.7pp
QoQ-11.6pp

Evolv Technologies Holdings, Inc.'s net profit margin was -32.9% in Q3 2026, showing the share of revenue converted to profit. This is down 28.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 11.6 percentage points.

Return on Equity
-14.4%
YoY-12.7pp
QoQ-6.6pp
5Y change-21.8pp

Evolv Technologies Holdings, Inc.'s quarterly ROE was -14.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 12.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.6 percentage points.

Capital Allocation

R&D Spending
$6.1M
YoY+9.2%
QoQ+6.0%

Evolv Technologies Holdings, Inc. invested $6.1M in research and development in Q3 2026. This represents an increase of 9.2% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.

Share Buybacks

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

EVLV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLV quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$47.3M+10.5%$43.8M+34.4%$46.3M+44.7%$38.5M+32.3%$42.9M+56.6%$32.5M+29.0%$32.0M+44.3%$29.1M+41.4%
Cost of Revenue$23.8M+10.5%$21.8M+33.5%$22.7M+76.8%$19.9M+60.8%$21.5M+86.5%$16.3M+56.0%$12.9M+28.2%$12.4M+12.2%
Gross Profit$23.5M+10.5%$22.0M+35.4%$23.6M+23.2%$18.6M+11.3%$21.3M+34.8%$16.2M+9.9%$19.1M+57.5%$16.7M+75.1%
R&D Expenses$6.1M+9.2%$5.8M+22.0%$5.9M+21.0%$5.4M+0.4%$5.6M-3.5%$4.7M-19.0%$4.9M-24.0%$5.4M-14.5%
SG&A Expenses$31.8M+31.0%$26.7M-7.8%$26.2M+0.7%$21.2M-29.8%$24.3M-16.1%$29.0M-4.7%$26.0M-6.0%$30.2M+18.6%
Operating Income-$14.4Mn/m-$10.6Mn/m-$8.5Mn/m-$8.0Mn/m-$8.6Mn/m-$17.5Mn/m-$14.4Mn/m-$18.9Mn/m
EBITDA-$6.9Mn/m-$3.5Mn/m-$1.7Mn/m-$1.5Mn/m-$2.1Mn/m-$11.7Mn/m-$8.9Mn/m-$13.4Mn/m
Interest Expense$982K+37.7%$965Kn/m$962K+96100.0%$1.0M$713Kn/m$0n/m$1Kn/mN/A
Income Tax$0n/m$0n/m-$37K-158.7%$0$0n/m-$1Kn/m$63Kn/mN/A
Net Income-$15.6Mn/m-$9.3Mn/m-$5.0Mn/m$10.9Mn/m-$1.8Mn/m-$40.5M-1285.9%-$1.7Mn/m-$15.7Mn/m
EPS (Basic)-$0.09n/m-$0.05n/m-$0.03n/m$0.06n/m-$0.01n/m-$0.25-1350.0%-$0.01n/m-$0.09n/m
EPS (Diluted)-$0.09n/m-$0.05n/m-$0.03n/m$0.06n/m-$0.01n/m-$0.25-1350.0%-$0.01n/m-$0.09n/m
Diluted Shares (Avg)181M+4.8%180M+9.0%177M+10.1%N/A173M+9.6%165M-3.7%161M+5.1%N/A

EVLV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLV quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$303.1M-0.4%$302.0M+7.7%$304.6M+19.0%$304.4M+13.6%$304.3M+9.3%$280.4M+4.2%$256.0M-8.6%$268.1M-9.8%
Current Assets$150.0M-1.1%$149.4M+12.3%$152.0M+46.5%$151.3M+24.6%$151.6M+12.8%$133.1M-3.1%$103.8M-24.9%$121.4M-29.9%
Cash & Equivalents$61.9M+96.5%$52.7M+42.6%$56.1M+123.5%$49.1M+32.8%$31.5M-31.6%$36.9M+3.5%$25.1M-43.7%$37.0M-44.9%
Short-Term Investments$5.0M-80.0%$9.9Mn/m$5.0M-49.7%$19.9M+33.2%$24.7M+148.2%$0-100.0%$9.9M-72.7%$14.9M-70.9%
Inventory$5.8M-33.9%$8.7M-28.7%$8.3M-17.9%$9.3M-45.1%$8.8M-46.1%$12.1M-36.5%$10.1M-12.7%$17.0M+64.0%
Accounts Receivable$50.4M+3.1%$39.6M-5.3%$42.7M+23.9%$30.8M+8.6%$48.9M+40.2%$41.8M+18.0%$34.5M+75.4%$28.4M+31.8%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$195.3M-3.4%$183.2M-2.5%$184.0M+36.4%$185.0M+23.0%$202.1M+35.2%$187.8M+59.3%$134.9M-3.8%$150.4M-1.7%
Current Liabilities$137.8M+15.5%$126.8M-11.2%$125.9M+33.3%$123.0M+27.2%$119.3M+33.4%$142.9M+78.4%$94.4M+23.6%$96.7M+19.0%
Non-Current Liabilities$57.5M-30.5%$56.3M+25.5%$58.1M+43.4%$62.0M+15.5%$82.7M+37.8%$44.9M+18.9%$40.5M-36.5%$53.7M-25.1%
Long-Term Debt$28.8M+1.0%$28.7M$28.7M$28.6Mn/m$28.5MN/AN/A$0n/m
Total Equity$107.8M+5.4%$118.9M+28.3%$120.7M-0.3%$119.4M+1.5%$102.2M-20.7%$92.7M-38.7%$121.1M-13.4%$117.7M-18.4%
Retained Earnings-$417.7Mn/m-$402.1Mn/m-$392.8Mn/m-$387.8Mn/m-$398.7Mn/m-$396.9Mn/m-$356.4Mn/m-$354.7Mn/m

Not reported in any period shown, so not listed: Goodwill.

EVLV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLV quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$18.0M+409.7%$11.9M+463.3%-$3.2Mn/m$15.6M+386.0%$3.5M-4.1%$2.1Mn/m-$2.5Mn/m$3.2Mn/m
Depreciation & Amortization$7.5M+15.4%$7.1M+22.4%$6.8M+23.0%$6.5M+19.1%$6.5M+41.3%$5.8M+48.7%$5.5M+60.0%$5.4M+73.8%
Stock-Based Compensation$6.9M+28.6%$6.9M+23.5%$5.6M+14.5%N/A$5.4M-28.2%$5.5M-25.3%$4.9M-24.1%N/A
Investing Cash Flow-$9.8Mn/m-$14.8M-357.4%$9.8Mn/m$1.4Mn/m-$39.6M-735.8%$5.8M-53.4%-$9.4Mn/m-$13.3Mn/m
Financing Cash Flow$280K-99.1%$245K-94.0%$322K+1510.0%$679K+3.2%$30.6M+5847.0%$4.1M+1120.1%$20K-93.4%$658K+1165.4%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

EVLV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLV quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin49.7%0.0pp50.2%+0.3pp50.9%-8.9pp48.4%-9.2pp49.7%-8.1pp49.8%-8.7pp59.8%+5.0pp57.5%+11.1pp
Operating Margin-30.4%-10.4pp-24.1%+29.6pp-18.3%+26.7pp-20.7%+44.1pp-20.1%+49.9pp-53.8%+34.9pp-45.0%+53.8pp-64.9%
Net Margin-32.9%-28.7pp-21.3%-10.8%-5.5pp28.3%+82.3pp-4.2%-124.6%-5.3%+45.5pp-54.0%+29.5pp
Return on Equity-14.4%-12.7pp-7.8%+35.9pp-4.2%-2.8pp9.1%+22.5pp-1.8%+21.8pp-43.8%-46.0pp-1.4%+6.7pp-13.4%-1.4pp
Return on Assets-5.1%-4.5pp-3.1%+11.4pp-1.6%-1.0pp3.6%+9.4pp-0.6%+10.3pp-14.4%-15.7pp-0.7%+3.4pp-5.9%-0.1pp
Current Ratio1.09-0.2x1.18+0.2x1.21+0.1x1.230.0x1.27-0.2x0.93-0.8x1.10-0.7x1.26-0.9x
Debt-to-Equity0.270.0x0.240.240.24+0.2x0.28N/AN/A0.000.0x
Liabilities-to-Equity1.81-0.2x1.54-0.5x1.52+0.4x1.55+0.3x1.98+0.8x2.03+1.2x1.11+0.1x1.28+0.2x
Asset Turnover0.160.0x0.140.0x0.150.0x0.130.0x0.140.0x0.120.0x0.130.0x0.110.0x

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Evolv Technologies Holdings, Inc. EVLV FY2025 $145.9M -$33.1M -22.7% $709.2M 66/100
Mistras Group Inc. MG FY2025 $724.0M $16.8M 2.3% $643.4M 44/100
Napco Security Technologies, Inc NSSC FY2026 $202.3M $43.0M 21.3% $1.1B 79/100
Comp X International Inc. CIX FY2025 $158.3M $19.5M 12.3% $529.1M 74/100
NLI Holdings, Inc. NL FY2025 $158.3M -$37.8M -23.9% $365.8M 54/100
CoreCivic, Inc. CXW FY2025 $2.2B $116.5M 5.3% $2.7B 55/100

Frequently Asked Questions

Evolv Technologies Holdings, Inc. (EVLV) reported $145.9M in total revenue for fiscal year 2025. This represents a 40.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Evolv Technologies Holdings, Inc. (EVLV) revenue grew by 40.5% year-over-year, from $103.9M to $145.9M in fiscal year 2025.

No, Evolv Technologies Holdings, Inc. (EVLV) reported a net loss of $19.0M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $33.1M, with a net profit margin of -22.7%.

Evolv Technologies Holdings, Inc. (EVLV) reported diluted earnings per share of -$0.20 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Evolv Technologies Holdings, Inc. (EVLV) had EBITDA of -$24.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Evolv Technologies Holdings, Inc. (EVLV) had $49.1M in cash and equivalents against $28.6M in long-term debt.

Evolv Technologies Holdings, Inc. (EVLV) had a gross margin of 51.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Evolv Technologies Holdings, Inc. (EVLV) had an operating margin of -33.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Evolv Technologies Holdings, Inc. (EVLV) had a net profit margin of -22.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Evolv Technologies Holdings, Inc. (EVLV) has a return on equity of -27.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Evolv Technologies Holdings, Inc. (EVLV) generated $18.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Evolv Technologies Holdings, Inc. (EVLV) had $304.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Evolv Technologies Holdings, Inc. (EVLV) invested $20.6M in research and development during fiscal year 2025.

Evolv Technologies Holdings, Inc. (EVLV) had 179M shares outstanding as of fiscal year 2025.

Evolv Technologies Holdings, Inc. (EVLV) had a current ratio of 1.23 as of fiscal year 2025, which is considered adequate.

Evolv Technologies Holdings, Inc. (EVLV) had a debt-to-equity ratio of 0.24 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Evolv Technologies Holdings, Inc. (EVLV) had a liabilities-to-equity ratio of 1.55 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Evolv Technologies Holdings, Inc. (EVLV) had a return on assets of -10.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Evolv Technologies Holdings, Inc. (EVLV) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $709.2M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Evolv Technologies Holdings, Inc. (EVLV) trades at 4.0x sales, its market capitalization divided by $175.9M revenue, trailing 12 months to September 30, 2026. The market capitalization is $709.2M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Evolv Technologies Holdings, Inc. (EVLV) has an Altman Z-Score of 0.58, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Evolv Technologies Holdings, Inc. (EVLV) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Evolv Technologies Holdings, Inc. (EVLV) reported a net loss of $33.1M while generating $18.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Evolv Technologies Holdings, Inc. (EVLV) reported an operating loss of $48.5M against $1.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Evolv Technologies Holdings, Inc. (EVLV) scores 66 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top